Related Experiment Videos
HIV type 1 envelope subtype C sequences from recent seroconverters in Zimbabwe
M Batra1, P C Tien, R W Shafer
1Center for AIDS Research, Stanford University School of Medicine, California 94305, USA.
AIDS Research and Human Retroviruses
|July 13, 2000
Summary
Analyzing human immunodeficiency virus type 1 (HIV-1) envelope sequences from Zimbabwe reveals significant genetic diversity within subtype C isolates. This diversity is crucial for developing effective HIV vaccines and understanding virus cell tropism.
Area of Science:
- Virology
- Immunology
- Genetics
Background:
- Human immunodeficiency virus type 1 (HIV-1) envelope sequence patterns influence viral cell tropism and vaccine development.
- Understanding the genetic characteristics of newly transmitted HIV-1 strains is essential for effective intervention strategies.
Purpose of the Study:
- To identify sequence characteristics of recently transmitted HIV-1 isolates in southern Africa.
- To analyze the genetic diversity and specific features of the HIV-1 envelope V3-V5 regions in Zimbabwean seroconverters.
Main Methods:
- Sequencing of the V3-V5 envelope regions from 24 male HIV-1 seroconverters in Harare, Zimbabwe.
- Phylogenetic analysis to determine isolate clustering and genetic distance.
- Identification of specific sequence features, including syncytium-inducing (SI) properties and mutations.
Main Results:
- All sequenced isolates belonged to HIV-1 subtype C, with a mean intersequence pairwise genetic distance of 17%.
- Three isolates exhibited syncytium-inducing (SI) properties.
- Specific mutations and sequence features, such as an unusual GIGK crown, codon 23 deletion, and high net positive charge in the V3 loop, were associated with SI activity.
Conclusions:
- The extensive genetic diversity within subtype C HIV-1 envelope sequences in this region poses challenges for vaccine development.
- Further research, including analysis of SI isolates and mutagenesis studies, is needed to elucidate the molecular basis of SI activity and its implications for HIV-1 pathogenesis and vaccine design.